Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Disorders of Breast”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT04480619
What this trial is testing

Safety and Efficacy of Ga68-IAC PET/CT for Diagnosis and Clinical Management in Metastatic Breast Cancer Patients

Who this might be right for
Angiogenic Breast Cancer
Advanced Imaging Projects, LLC 25
Not applicableStudy completedNCT03619993
What this trial is testing

Patient Preference for Pegfilgrastim (Neulasta®) Application Forms

Who this might be right for
Non Hodgkin LymphomaBreast Cancer
iOMEDICO AG 404
Testing effectiveness (Phase 2)Active Not RecruitingNCT03384914
What this trial is testing

Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer

Who this might be right for
Breast Cancer FemaleBreast Cancer, MaleBreast Cancer Stage I+5 more
H. Lee Moffitt Cancer Center and Research Institute 119
Very early researchWithdrawnNCT03388814
What this trial is testing

Speeding Recovery From Pain and Opioid Use

Who this might be right for
Pain, PostoperativeBreast CancerOpioid Use+1 more
Wake Forest University Health Sciences
Large-scale testing (Phase 3)Looking for participantsNCT06915857
What this trial is testing

Topical Betamethasone Versus Moisturizer in Preventing Radiation Dermatitis in Large-Breasted Patients Treated in the Prone Position

Who this might be right for
Breast CancerRadiation Dermatitis
Sunnybrook Health Sciences Centre 276
Testing effectiveness (Phase 2)Active Not RecruitingNCT03941730
What this trial is testing

Estradiol in Treating Patients With ER Beta Positive, Triple Negative Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Advanced Triple-Negative Breast CarcinomaAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8+2 more
Mayo Clinic 8
Testing effectiveness (Phase 2)Looking for participantsNCT05918328
What this trial is testing

Comparing the Efficacy of Nab-PH+Pyrrolitinib and TCbHP in the Neoadjuvant Treatment of HER2 Positive BC

Who this might be right for
Breast CancerHER2-positive Breast Cancer
Henan Cancer Hospital 610
Testing effectiveness (Phase 2)Looking for participantsNCT07283692
What this trial is testing

Neoadjuvant Serplulimab Plus Weekly Paclitaxel and Carboplatin in TNBC (Neo-SERPENT)

Who this might be right for
Triple Negative Breast Cancer
RenJi Hospital 46
Post-approval studies (Phase 4)Study completedNCT03583944
What this trial is testing

Evaluate Safety, Tolerability and Efficacy of Eribulin Mesylate in Treating Adult Females With Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Breast Neoplasms
Eisai Inc. 200
Not applicableStudy completedNCT01314963
What this trial is testing

Efficacy of Gamma Camera Used Intraoperatively for ID of Sentinel Lymph Nodes w/ Lymphoscintigraphy

Who this might be right for
Multiple MyelomaBreast Cancer
Stanford University 50
Not applicableLooking for participantsNCT05042687
What this trial is testing

Comparative Performance of Molecular Breast Imaging (MBI) to Magnetic Resonance Imaging (MRI) of the Breast in Identifying and Excluding Breast Carcinoma in Women at High Risk for Breast Cancer

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 300
Testing effectiveness (Phase 2)Study completedNCT01127763
What this trial is testing

RAD001 Plus Carboplatin in Breast Cancer Patients

Who this might be right for
Breast Cancer
NYU Langone Health 25
Not applicableStudy completedNCT02829021
What this trial is testing

Dynamic Infrared Thermography in Breast Cancer Diagnostics

Who this might be right for
Breast Cancer
University Hospital of North Norway 168
Early research (Phase 1)Study completedNCT01372644
What this trial is testing

Breast Cancer Chemoprevention by SOM230, an IGF-I Action Inhibitor: A Proof of Principle Trial

Who this might be right for
Atypical Ductal Breast HyperplasiaLobular Carcinoma in Situ (LCIS)Atypical Lobular Hyperplasia (ALH) of Breast
NYU Langone Health 15
Not applicableUnknownNCT02617264
What this trial is testing

Spot tm Tattooing of Biopsied Axillary Lymph Nodes With Ultrasound Guided in Breast Cancer Patients Prior to Surgery

Who this might be right for
Breast Cancer
Kaplan Medical Center 50
Early research (Phase 1)WithdrawnNCT03045393
What this trial is testing

Mirvetuximab Soravtansine (IMG853) in Folate Receptor Alpha-expressing TNBC

Who this might be right for
Breast Cancer Triple Negative
Duke University
Not applicableLooking for participantsNCT06877416
What this trial is testing

Analysis of Exploring Optimized Sequential Treatment Strategies of Antibody-Drug Conjugates (ADCs) in HER2-Low-Expressing Breast Cancer

Who this might be right for
Antibody-drug ConjugatesHER2-low Breast CancerBreast Neoplasms
Sun Yat-sen University 700
Testing effectiveness (Phase 2)UnknownNCT05403333
What this trial is testing

Weekly Utidelone in HER2-negative Inoperable Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Breast NeoplasmsLocally Advanced or Metastatic Breast Cancer
Fudan University 61
Early research (Phase 1)Study completedNCT04541433
What this trial is testing

AZD9833 in Japanese Women With ER Positive, HER2 Negative Advanced Breast Cancer

Who this might be right for
ER+ HER2- Advanced Breast Cancer
AstraZeneca 10
Testing effectiveness (Phase 2)WithdrawnNCT01288092
What this trial is testing

BEZ235 Trial in Patients With HER2-(Human Epidermal Growth Factor Receptor 2 Negative) /HR+ (Hormonal Receptor Positive) Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Novartis Pharmaceuticals
Next Page